Anupam Rasayan Announces Open Offer for Bliss GVS Pharma Ltd Stake
Anupam Rasayan India Limited has initiated an open offer for Bliss GVS Pharma Ltd, seeking to acquire a substantial stake from the company's public shareholders. The open offer, which represents a mandatory acquisition, has an offer price of ₹ 299.00 per equity share.The open offer aims to acquire up to 2,77,26,848 fully paid-up equity shares, representing 26.00% of Bliss GVS Pharma Ltd's Expanded Voting Share Capital. Assuming full acceptance of the offer, the total consideration payable by Anupam Rasayan India Limited will amount to up to ₹ 8,29,03,27,552.00, paid entirely in cash.
Underlying Acquisition Triggers Open Offer
The open offer is prompted by a larger transaction where Anupam Rasayan India Limited executed a share purchase agreement with several existing sellers. Under the terms of the agreement dated May 23, 2026, the Acquirer agreed to acquire 4,58,03,024 equity shares from the sellers. These shares represent 43.30% of the equity share capital of Bliss GVS Pharma Ltd as of the transaction date.The sale and purchase of these shares are proposed at a price not exceeding ₹ 299.00 per equity share, payable in one or more tranches. The total consideration for this Underlying Transaction amounts to ₹ 13,69,51,04,176.00.
The Underlying Transaction establishes the Acquirer's position, leading to the mandatory open offer to achieve a significant stake in the target company.
Key Figures and Offer Details
The details of the proposed open offer and the underlying transaction are summarized below:| Metric | Detail | Value |
|---|---|---|
| Target Company | Bliss GVS Pharma Ltd | N/A |
| Acquirer | Anupam Rasayan India Limited | N/A |
| Open Offer Size | Shares to be acquired from Public Shareholders | Up to 2,77,26,848 Equity Shares |
| Open Offer Percentage | % of Expanded Voting Share Capital | 26.00% |
| Offer Price | Price per Equity Share | ₹ 299.00 |
| Total Consideration | Max payout under Open Offer | ₹ 8,29,03,27,552.00 |
| Underlying Transaction Shares | Shares acquired from Sellers | 4,58,03,024 Equity Shares |
| Underlying Consideration | Total consideration for SPA | ₹ 13,69,51,04,176.00 |
Seller Holdings in Bliss GVS Pharma Ltd
The transaction involves multiple selling shareholders, categorized as promoter and non-promoter sellers. The total combined holdings of these sellers amount to 50,984,595 equity shares.| Seller Name | Promoter Group | Pre-Transaction Shares | % of Equity Share Capital | Post-Transaction Shares (Option Shares) | % of Expanded Voting Share Capital |
|---|---|---|---|---|---|
| Shruti Vishal Rao | Yes | 2,110,000 | 1.99% | 0 | 0.00% |
| Vibha Gagan Sharma | Yes | 2,575,000 | 2.43% | 0 | 0.00% |
| Narsimha Shibroor Kamath | Yes | 32,437,024 | 30.66% | 37,00,000 | 3.47% |
| Gautam Rasiklal Ashra | No | 2,981,571 | 2.82% | 9,31,571 | 0.87% |
| Arjun Gautam Ashra | No | 5,049,000 | 4.77% | 5,50,000 | 0.52% |
| Gulbarga Trading and Investment Private Limited | No | 5,832,000 | 5.51% | 0 | 0.00% |
| Total Sellers | 50,984,595 | 48.19% | 51,81,571 | 4.86% |
The open offer was managed by SBI Capital Markets Limited, acting for and on behalf of Anupam Rasayan India Limited.
BLISSGVS Stock Price Movement
Shares of Bliss GVS Pharma Limited are edging higher to ₹317.95 as of 11:51 AM, rallying a notable ₹17.60 or 5.86% in live trading. With significant trading activity reflected by 7.99 million shares traded, the stock has notably pushed up to mark its 52-week high at ₹329.2.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: